|
Fig. 1. A WNT11 variant associated with laterality, heart and kidney
developmental defects
(A) Pedigree indicating clinical features and segregation of the identified WNT11c.814delG
variant amongst the three family members. (B) Chromatogram traces of Sanger
sequencing results regarding the WNT11 variant segregation within the family, showing
a homozygous deletion of c.814G in the affected child while both parents areheterozygous. In (A,B), I.1 = father; I.2 = mother; II.1 = son. (C,D) Alphafold 2.1.2
protein structure predictions of human (WNT11) and Xenopus (Wnt11b) Wnt ligands,
and comparison of the WNT11c.814delG variant to dominant-negative (dn)Wnt11b. (D)
Magnification of C-termini of truncated ligands with annotation of the last amino acids.
Red arrows indicate C-terminal end.
|
|
Fig. 1. A WNT11 variant associated with laterality, heart and kidney
developmental defects
(A) Pedigree indicating clinical features and segregation of the identified WNT11c.814delG
variant amongst the three family members. (B) Chromatogram traces of Sanger
sequencing results regarding the WNT11 variant segregation within the family, showing
a homozygous deletion of c.814G in the affected child while both parents areheterozygous. In (A,B), I.1 = father; I.2 = mother; II.1 = son. (C,D) Alphafold 2.1.2
protein structure predictions of human (WNT11) and Xenopus (Wnt11b) Wnt ligands,
and comparison of the WNT11c.814delG variant to dominant-negative (dn)Wnt11b. (D)
Magnification of C-termini of truncated ligands with annotation of the last amino acids.
Red arrows indicate C-terminal end.
|
|
Fig. 2. Functional testing of the WNT11c.814delG variant in Xenopus embryos
(A-D) Overexpression of mRNAs (at 70ng/l) encoding WNT11, Wnt11b, WNT11c.814delG
and dnWnt11b, and analysis of effects on (A,B) morphogenesis at st. 13 (posterior
view) and 20 (dorso-anterior view), (C,D) and left-right axis patterning (lateral views) by
WMISH at st. 30 - 32 against pitx2c. (A,D) Representative images. In (A), neural folds
(nf) and blastopores (bp) are indicated by yellow and magenta dashed lines,
respectively. In (D), filled green arrowheads indicate normal left-sided expression, open
white arrowheads indicate normal right-sided lack of expression. Filled magenta
arrowheads indicate ectopic right-sided expression, open magenta arrowheads indicate
loss of left-sided expression. (B,C) Quantification of results. n = number of embryos
analyzed per condition.
2
-test, p > 0.05 = ns; p < 0.05 = *; p < 0.01 = **; p < 0.001 =
***. In (B), embryos were derived from 6 different batches (different parents) for Uninj.
Ctrl., Inj. Ctrl., WNT11, WNT11c.814delG, and from 5 different batches for wnt11b and
dnwnt11b conditions. In (C), embryos were derived from 4 different batches (different
parents) for all conditions. In (A) and (D), all embryos from the same experiment are
shown in the same magnification.
|
|
Fig. 2. Functional testing of the WNT11c.814delG variant in Xenopus embryos
(A-D) Overexpression of mRNAs (at 70ng/l) encoding WNT11, Wnt11b, WNT11c.814delG
and dnWnt11b, and analysis of effects on (A,B) morphogenesis at st. 13 (posterior
view) and 20 (dorso-anterior view), (C,D) and left-right axis patterning (lateral views) by
WMISH at st. 30 - 32 against pitx2c. (A,D) Representative images. In (A), neural folds
(nf) and blastopores (bp) are indicated by yellow and magenta dashed lines,
respectively. In (D), filled green arrowheads indicate normal left-sided expression, open
white arrowheads indicate normal right-sided lack of expression. Filled magenta
arrowheads indicate ectopic right-sided expression, open magenta arrowheads indicate
loss of left-sided expression. (B,C) Quantification of results. n = number of embryos
analyzed per condition.
2
-test, p > 0.05 = ns; p < 0.05 = *; p < 0.01 = **; p < 0.001 =
***. In (B), embryos were derived from 6 different batches (different parents) for Uninj.
Ctrl., Inj. Ctrl., WNT11, WNT11c.814delG, and from 5 different batches for wnt11b and
dnwnt11b conditions. In (C), embryos were derived from 4 different batches (different
parents) for all conditions. In (A) and (D), all embryos from the same experiment are
shown in the same magnification.
|
|
Fig. 3. Changes in C-terminal amino acids alters WNT11c.814delG function
(A) Schematic representation of constructs and their lengths. Human WNT11 constructs
are shown in blue, Xenopus Wnt11b constructs are shown in green. Orange indicates
changes in the sequence. (B-E) Overexpression of mRNAs (at 70ng/l) encoding
WNT11, WNT11c.814delG
, WNT11814-1062
, WNT11850-1062
, dnWnt11b and Wnt11b811-
1059
, and analysis of effects on (B,C) morphogenesis at st. 17 (dorso-anterior view), and
(D,E) left-right axis patterning (lateral views) by WMISH at st. 30 - 32 against pitx2c.
(B,E) Representative images. In (B), neural folds (nf) are indicated by yellow dashed
lines. In (E), filled green arrowheads indicate normal left-sided expression, open white
arrowheads indicate normal right-sided lack of expression. Filled magenta arrowheads
indicate ectopic right-sided expression, open magenta arrowheads indicate loss of leftsided expression. (C,D) Quantification of results. n = number of embryos analyzed per
condition.
2
-test, p > 0.05 = ns; p < 0.05 = *; p < 0.01 = **; p < 0.001 = ***. In (C),
embryos were derived from 6 different batches (different parents) for Uninj. Ctrl., Inj.
Ctrl., WNT11814-1062
, WNT11850-1062
, Wnt11b811-1059, from 5 different batches for
dnwnt11b, and from 3 different batched for WNT11c.814delG conditions. In (D), embryos
were derived from 3 different batches (different parents) for all conditions. In (B) and
(E), all embryos from the same experiment are shown in the same magnification.
|
|
Fig. 3. Changes in C-terminal amino acids alters WNT11c.814delG function
(A) Schematic representation of constructs and their lengths. Human WNT11 constructs
are shown in blue, Xenopus Wnt11b constructs are shown in green. Orange indicates
changes in the sequence. (B-E) Overexpression of mRNAs (at 70ng/l) encoding
WNT11, WNT11c.814delG
, WNT11814-1062
, WNT11850-1062
, dnWnt11b and Wnt11b811-
1059
, and analysis of effects on (B,C) morphogenesis at st. 17 (dorso-anterior view), and
(D,E) left-right axis patterning (lateral views) by WMISH at st. 30 - 32 against pitx2c.
(B,E) Representative images. In (B), neural folds (nf) are indicated by yellow dashed
lines. In (E), filled green arrowheads indicate normal left-sided expression, open white
arrowheads indicate normal right-sided lack of expression. Filled magenta arrowheads
indicate ectopic right-sided expression, open magenta arrowheads indicate loss of leftsided expression. (C,D) Quantification of results. n = number of embryos analyzed per
condition.
2
-test, p > 0.05 = ns; p < 0.05 = *; p < 0.01 = **; p < 0.001 = ***. In (C),
embryos were derived from 6 different batches (different parents) for Uninj. Ctrl., Inj.
Ctrl., WNT11814-1062
, WNT11850-1062
, Wnt11b811-1059, from 5 different batches for
dnwnt11b, and from 3 different batched for WNT11c.814delG conditions. In (D), embryos
were derived from 3 different batches (different parents) for all conditions. In (B) and
(E), all embryos from the same experiment are shown in the same magnification.
|
|
Fig. 4. WNT11c.814delG encodes a loss-of-function variant
(A,B) Unilateral, right-sided overexpression of mRNAs (at 100ng/l) encoding
WNT11c.814delG
, WNT11814-1062 and WNT11850-1062, and analysis of effects on Wnt/-
catenin signaling reporter (pbinLEF::dGFP) activity (green). (A) Representative images.
(B) Quantification of results. n = number of embryos analyzed per condition.
2
-test, p >
0.05 = ns; p < 0.05 = *; p < 0.01 = **; p < 0.001 = ***. (C,D) Overexpression of mRNAs
(at 100ng/l) encoding WNT11, WNT11c.814delG
, WNT11814-1062
, WNT11850-1062 and
Wnt11b, and analysis of (C) protein expression levels as well as (D) dimerization of
ligands using Western blotting. -WNT11 = anti-human WNT11 antibody; -Tub. = antialpha-Tubulin antibody (loading control). Semi-quantitative analysis of WNT11 protein
levels (graphs) show fold change of band intensities (normalized by loading control)
over uninjected control sample (uninj. ctrl.). Magenta = upper bands (dimers; 50-80
kDa), cyan = lower bands (monomers; 25-45 kDa). Full membranes are shown in
supplemental figure S3C and D. In (A), embryos were derived from 2 different batches
(different parents) for all conditions, and all embryos are shown in the same
magnification.
|
|
Fig. 4. WNT11c.814delG encodes a loss-of-function variant
(A,B) Unilateral, right-sided overexpression of mRNAs (at 100ng/l) encoding
WNT11c.814delG
, WNT11814-1062 and WNT11850-1062, and analysis of effects on Wnt/-
catenin signaling reporter (pbinLEF::dGFP) activity (green). (A) Representative images.
(B) Quantification of results. n = number of embryos analyzed per condition.
2
-test, p >
0.05 = ns; p < 0.05 = *; p < 0.01 = **; p < 0.001 = ***. (C,D) Overexpression of mRNAs
(at 100ng/l) encoding WNT11, WNT11c.814delG
, WNT11814-1062
, WNT11850-1062 and
Wnt11b, and analysis of (C) protein expression levels as well as (D) dimerization of
ligands using Western blotting. -WNT11 = anti-human WNT11 antibody; -Tub. = antialpha-Tubulin antibody (loading control). Semi-quantitative analysis of WNT11 protein
levels (graphs) show fold change of band intensities (normalized by loading control)
over uninjected control sample (uninj. ctrl.). Magenta = upper bands (dimers; 50-80
kDa), cyan = lower bands (monomers; 25-45 kDa). Full membranes are shown in
supplemental figure S3C and D. In (A), embryos were derived from 2 different batches
(different parents) for all conditions, and all embryos are shown in the same
magnification.
|
|
Fig. 4. WNT11c.814delG encodes a loss-of-function variant
(A,B) Unilateral, right-sided overexpression of mRNAs (at 100ng/l) encoding
WNT11c.814delG
, WNT11814-1062 and WNT11850-1062, and analysis of effects on Wnt/-
catenin signaling reporter (pbinLEF::dGFP) activity (green). (A) Representative images.
(B) Quantification of results. n = number of embryos analyzed per condition.
2
-test, p >
0.05 = ns; p < 0.05 = *; p < 0.01 = **; p < 0.001 = ***. (C,D) Overexpression of mRNAs
(at 100ng/l) encoding WNT11, WNT11c.814delG
, WNT11814-1062
, WNT11850-1062 and
Wnt11b, and analysis of (C) protein expression levels as well as (D) dimerization of
ligands using Western blotting. -WNT11 = anti-human WNT11 antibody; -Tub. = antialpha-Tubulin antibody (loading control). Semi-quantitative analysis of WNT11 protein
levels (graphs) show fold change of band intensities (normalized by loading control)
over uninjected control sample (uninj. ctrl.). Magenta = upper bands (dimers; 50-80
kDa), cyan = lower bands (monomers; 25-45 kDa). Full membranes are shown in
supplemental figure S3C and D. In (A), embryos were derived from 2 different batches
(different parents) for all conditions, and all embryos are shown in the same
magnification.
|
|
Fig. 4. WNT11c.814delG encodes a loss-of-function variant
(A,B) Unilateral, right-sided overexpression of mRNAs (at 100ng/l) encoding
WNT11c.814delG
, WNT11814-1062 and WNT11850-1062, and analysis of effects on Wnt/-
catenin signaling reporter (pbinLEF::dGFP) activity (green). (A) Representative images.
(B) Quantification of results. n = number of embryos analyzed per condition.
2
-test, p >
0.05 = ns; p < 0.05 = *; p < 0.01 = **; p < 0.001 = ***. (C,D) Overexpression of mRNAs
(at 100ng/l) encoding WNT11, WNT11c.814delG
, WNT11814-1062
, WNT11850-1062 and
Wnt11b, and analysis of (C) protein expression levels as well as (D) dimerization of
ligands using Western blotting. -WNT11 = anti-human WNT11 antibody; -Tub. = antialpha-Tubulin antibody (loading control). Semi-quantitative analysis of WNT11 protein
levels (graphs) show fold change of band intensities (normalized by loading control)
over uninjected control sample (uninj. ctrl.). Magenta = upper bands (dimers; 50-80
kDa), cyan = lower bands (monomers; 25-45 kDa). Full membranes are shown in
supplemental figure S3C and D. In (A), embryos were derived from 2 different batches
(different parents) for all conditions, and all embryos are shown in the same
magnification.
|
|
Fig. S1.
|
|
Fig. S1.
|
|
Fig. S1.
|
|
Fig. S2.
|
|
Fig. S2.
|
|
Fig. S3.
|
|
Fig. S3.
|
|
Fig. S3.
|